Kingsview Wealth Management’s iShares US Technology ETF IYW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$913K Sell
3,619
-1,726
-32% -$396K 0.01% 774
2026
Q1
$970K Buy
5,345
+810
+18% +$157K 0.01% 703
2025
Q4
$905K Sell
4,535
-181
-4% -$36.2K 0.01% 668
2025
Q3
$924K Sell
4,716
-55
-1% -$10.1K 0.01% 634
2025
Q2
$827K Buy
4,771
+1,061
+29% +$161K 0.01% 634
2025
Q1
$521K Buy
3,710
+1,447
+64% +$225K 0.01% 713
2024
Q4
$361K Buy
2,263
+244
+12% +$38.6K 0.01% 837
2024
Q3
$306K Sell
2,019
-1,026
-34% -$151K 0.01% 880
2024
Q2
$458K Sell
3,045
-107
-3% -$14.8K 0.01% 714
2024
Q1
$426K Buy
3,152
+1,269
+67% +$165K 0.01% 708
2023
Q4
$231K Sell
1,883
-9,166
-83% -$1.04M 0.01% 851
2023
Q3
$1.16M Buy
+11,049
New +$1.2M 0.04% 401

Other funds holding IYW

Kingsview Wealth Management's IYW Position: Q2 2026 in Review

Kingsview Wealth Management reduced its iShares US Technology ETF (IYW) stake by 32% in Q2 2026, selling an estimated $396K and leaving 3,619 shares worth $913K. The position accounts for 0.01% of the portfolio, ranked #774.

Kingsview Wealth Management first reported a position in IYW in Q3 2023 and has held it in 12 quarters since. The position peaked at $1.16M in Q3 2023. 1,296 funds tracked by Wall St. Rank hold IYW as of Q2 2026.

  • Kingsview Wealth Management held 3,619 shares of iShares US Technology ETF worth $913K as of Q2 2026.
  • Kingsview Wealth Management sold 1,726 iShares US Technology ETF shares in Q2 2026, an estimated $396K.
  • iShares US Technology ETF made up 0.01% of Kingsview Wealth Management's portfolio in Q2 2026, its #774 holding.
  • Kingsview Wealth Management first reported a position in iShares US Technology ETF in Q3 2023 and has held it in 12 quarters since.
  • Kingsview Wealth Management's iShares US Technology ETF position peaked at $1.16M in Q3 2023.
  • 1,296 funds tracked by Wall St. Rank held iShares US Technology ETF as of Q2 2026.

Based on Kingsview Wealth Management's 13F filing for Q2 2026, filed 19 Aug 2026.